Active Pharmaceutical Ingredient API News and Research

RSS

Dome9 Security announces multi-cloud security management platform

Dome9 Security, the leading provider of cloud security management for public and private clouds, as well as for dedicated and virtual private servers (VPS), today at TechCrunch Disrupt 2011 announced the general availability of its new first-of-its-kind, multi-platform security management service that automates cloud server security for both enterprises and cloud hosting providers.

12 Sep 2011

AMRI second quarter total revenue increases 9% to $53.9 million

AMRI today reported financial and operating results for the second quarter ended June 30, 2011.

8 Aug 2011

Unigene second quarter revenue decreases to $2.5 million

Unigene Laboratories, Inc. a leader in the design, delivery, manufacture and development of peptide-based therapeutics announced second quarter financial results for the period ended June 30, 2011. The Company highlighted significant progress achieved in the second quarter with the continued execution of its turnaround strategy.

8 Aug 2011

BioCryst second quarter total revenues decrease to $3.7 million

BioCryst Pharmaceuticals, Inc. announced financial results for the second quarter and six months ended June 30, 2011.

4 Aug 2011

Panasonic releases solution with gesture-based interfaces for digital entertainment and signage

Panasonic Electric Works Co., Ltd. announced today the release of a bundled solution for the digital entertainment and signage markets.

From PHC Europe B.V. 3 Aug 2011

FDA approves Lannett's ANDA for Phentermine Resin Extended-Release Capsules

Lannett Company, Inc. today announced the U.S. Food and Drug Administration (FDA) approved its Abbreviated New Drug Application (ANDA) for Phentermine Resin Extended-Release Capsules, 15 mg and 30 mg, representing the fourth product approval the company has received in the last five weeks.

29 Jul 2011

Dr. Reddy's, FUJIFILM sign MoU to enter partnership in the generic drugs business

FUJIFILM Corporation President and CEO, Shigetaka Komori and Dr. Reddy's Laboratories Ltd. Vice-Chairman and CEO, G V Prasad today signed a Memorandum of Understanding to enter into an exclusive partnership in the generic drugs business for the Japanese market and to establish a joint venture in Japan.

28 Jul 2011

Teva second quarter net sales increase 11% to $4.2 billion

Teva Pharmaceutical Industries Ltd. today reported results for the quarter ended June 30, 2011.

27 Jul 2011

Gilead announces expansion of global access program for HIV medications

Gilead Sciences, Inc. announced today an expansion of its global access program in an effort to provide accelerated access to Gilead medicines for the treatment of HIV/AIDS.

12 Jul 2011

Chengdu Tianyin files renewal application for High Tech Enterprise Status

Tianyin Pharmaceutical Co., Inc., a pharmaceutical company that specializes in patented biopharmaceutical medicine, modernized traditional Chinese medicine, branded generics and active pharmaceutical ingredients today announced that the operating subsidiary of TPI, Chengdu Tianyin Pharmaceutical, has submitted the application for the renewal of its High Tech Enterprise Status at Chengdu, Sichuan Province of China.

20 Jun 2011

Orexo completes first OX27 pharmacokinetic trial against breakthrough pain in cancer

Orexo AB announces a successful outcome following completion of the first OX27 pharmacokinetic trial.

14 Jun 2011

Mylan plans to change name of Matrix Laboratories

Mylan Inc. today announced that it plans to rebrand its Hyderabad, India-based subsidiary Matrix Laboratories Limited as Mylan.

27 May 2011

DTU purchases T-Ray 4000 system from Picometrix for terahertz time-domain studies

Advanced Photonix, Inc. today announced that the Lyngby campus of The Technical University of Denmark has purchased a T-Ray 4000 from its wholly-owned subsidiary, Picometrix, for terahertz time-domain studies.

24 May 2011

Neuland Labs fiscal 2011 revenues increase 41% to $88.8 million

Neuland Laboratories Ltd., a pharmaceutical manufacturer providing active pharmaceutical ingredients, complex intermediates, and contract research and manufacturing services to customers located in 85 countries, today announced financial results for the 2011 fiscal year ended March 31, 2011.

20 May 2011

Momentive Performance Materials collaborates with SSF to develop combination products

Momentive Performance Materials Inc. today announced a collaboration initiative with Specialty Silicone Fabricators (SSF) to develop combination products for medical devices manufacturers.

18 May 2011

Epichem signs exclusive distributor agreement with AR Brown

Australian supplier of API analytical standards Epichem, announced today it has signed an exclusive distributor agreement with a leading Japanese Life Sciences supplier company, AR Brown, for sales to Japan, Taiwan, China and South Korea.

17 May 2011

GenoLogics enhances LIMS software for next-generation genomics labs

GenoLogics, a leading provider of laboratory information management system (LIMS) software for next-generation genomics labs, today announced a detailed product roadmap for its eponymous LIMS, designed to provide the scalability, adaptability and usability features necessary for mainstream adoption of the most advanced sequencing technologies while supporting existing genotyping platforms.

11 May 2011

Unigene first quarter net loss decreases 58% to $6.6 million

Unigene Laboratories, Inc. a leader in the design, delivery, manufacture and development of peptide-based therapeutics announced first quarter financial results for the period ended March 31, 2011. The Company highlighted significant progress achieved in the first quarter with the execution of its turnaround strategy.

9 May 2011

Almac launches six enzyme screening kits

As anticipated, Almac's biocatalysis business has expanded from its 2009 launch with the sale of six enzyme screening kits, to the current supply of 100s of kgs of chiral intermediates for drug substance manufacture, regular enzyme supply to specialty chemical companies and continued growth of its screening kits offering. Biocatalysis is increasingly recognised as an alternative solution for solving complex chemistry problems due to its rapid implementation, economic benefits and 'green' reputation.

4 May 2011